Cookie information is stored in your browser and performs functions such as recognisin Log In. Researching ZS Pharma (NASDAQ:ZSPH) stock? RiverVest and Salem Partners are the most recent investors. ZS Pharma, Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. LiveStock & Poultry Medicine , Vaccines & Nutraceutical Products Zscaler (NASDAQ:ZS) was upgraded by equities research analysts at TheStreet from a “d” rating to a “c-” rating in a research note issued to investors on Tuesday, TheStreetRatingsTable reports. ZS Pharma. Follow ZSPH. Free trial. 3 Quality Buy and Hold Stocks for Long Term Investors. The agent name of this company is: C T CORPORATION SYSTEM , and company's status is listed as Active now. Free trial . ZS | Complete Zscaler Inc. stock news by MarketWatch. En novembre 2015, AstraZeneca acquiert ZS Pharma, une entreprise pharmaceutique américaine, pour 2,7 milliards de dollars [9]. September 24, 2014, 4:46 AM. Its core focus is the research and development of highly selective ion-trap therapies to treat serious medical conditions. Nabisco plant to close, … Zs Pharma, Inc. has … Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. Monthly Subscription. He is also on the board of Nanoscope Therapeutics, Inc. ZS Pharma dropped 3.1 percent on Thursday to close at $63.31, taking its market value to $1.59 billion. ZSPH / ZS Pharma, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index. Recurring Once. ZSPH : ZS Pharma, Inc. SEC CIK 0001459266 Ticker: ZSPH. ZS Pharma is part of the Healthcare business sector. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. The ZS Pharma brand, founded in 2008 (United States), has more than 546 sister brands and more than 22 510 competing brands. Latest Stock Picks Investing Basics ... Stock Advisor launched in February of 2002. Big Cap Pro. View ZSPH's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Berenberg Bank raised shares of Zscaler from a “hold” rating to a “buy” rating […] For financial reporting, their fiscal year ends on December 31st. For all future releases Just for the upcoming release Send me a reminder 1 trading day before ZS Pharma (NASDAQ: ZSPH) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. 89.98 0.00 (0.0%) Upgrade to Real-Time Afterhours (Closed) Best deals to access real time data! ZS Pharma (ZSPH) stock is spiking in late morning trading on Friday, after the biopharmaceutical company agreed to be acquired by AstraZeneca (AZN) for $2.7 billion. The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its sector. ZS PHARMA, INC. was registered on Oct 06, 2016 as a stock type company located at 1100 PARK PL STE 300, SAN MATEO, CA 94403 . MarketBeat: Week in Review 2/1 – 2/5. 26 talking about this. S&P 500 0.00%. Rooms Shows Rankings Earnings Calendar Shop. ZS Pharma stock roared higher after the Bloomberg report, closing with a 28.4% gain at $74.73 that pushed the company's market cap closer to $2 billion. Frequency. Upon completion, ZS Pharma, which has around 200 employees across three sites in California, Texas and Colorado, will become a wholly owned subsidiary of AstraZeneca. Real-time trade and investing ideas on ZS Pharma ZSPH from the largest community of traders and investors. $52.04. Get instant access to a free live streaming chart of the Zs Pharma I Stock. ZS Pharma Inc Stock Institutional Ownership and Insider Ownership - : the historical trend of stock ownership among institutions and insiders. ZS PHARMA INC : Cours de bourse, graphiques, cotations, conseils boursiers, données financières, analyses et actualités en temps réel de l'action ZS PHARMA INC | Nasdaq The company valuation of ZS Pharma, Inc, according to these metrics is way below the market valuation of its peer group. for only. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. The ISIN, the company's International Securities Identification Number, is GB0009895292. for only. ZS Pharma, Inc. (US:ZSPH) has 6 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). QQQ 331.36. ZS Pharma is funded by 10 investors. ZS Pharma NASDAQ Updated Jan … AstraZeneca has agreed to acquire ZS Pharma and its promising therapy for hyperkalaemia. ZS Pharma, Inc is primarely in the business of pharmaceutical preparations. Zacks Equity Research . Largest shareholders include . Read full article. Le même mois, AstraZeneca vend des licences sur certains médicaments concernant la maladie de Crohn à Perrigo pour 380 millions de dollars [10]. $33.03. Cancel. A number of other analysts also recently issued reports on the stock. S&P 500 3,886.83. ZS Pharma has raised a total of $123M in funding over 5 rounds. ZS Pharma, Inc. was a big mover last session, as the company saw its shares rise nearly 11% on the day.The move came on solid volume too with far more shares changing hands than in a normal session. ZS Pharma is a brand of AstraZeneca listed on the Frankfurt stock exchange. Read Next DOW 31,148.24. This reverses the recent downtrend for the company, as the stock has lost over 8% since Aug 26. ZS Pharma is registered under the ticker NASDAQ:ZSPH . ZS Pharma (ZSPH) stock is up this morning after the company had its price target raised at JPMorgan to $75 from $57. Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value. Founder of ZS Pharma, Inc. and Renibus Therapeutics, Inc., Alvaro F. Guillem currently occupies the position of Chairman & Chief Executive Officer at Renibus Therapeutics, Inc., Chairman at OncoNano Medicine, Inc. and President of ZS Pharma, Inc. ZS PHARMA, INC. (ZSPH) stock price, charts, trades & the US's most popular discussion forums. ZS Pharma: Astra Zeneca to Acquire ZS Pharma at $90 per Share-DARN (ZSPH, $90) Posted by Larry Smith on Nov 8, 2015 • ( 2 ) O n Friday, November 9, 2015 Astra Zeneca entered into a definitive agreement to buy ZS Pharma in an all-cash tender offer for all outstanding shares of ZS Pharma common stock at a price of $90 per share. ZS Pharma (ZSPH) in Focus: Stock Moves 10.7% Higher. Follow Zs Pharma I's earnings. Free forex prices, toplists, indices and lots more. Free forex prices, toplists, indices and lots more. Monthly Subscription. Their stock opened with $27.00 in its Jun 19, 2014 IPO. Stock Ticker Lookup. ZS Pharma is a privately held specialty pharmaceutical company based in Coppell, Texas, and Menlo Park, CA. ZS PHARMA, INC. (ZSPH) stock price, charts, trades & the US's most popular discussion forums. The move came on pretty good volume too. Search / Go. Under the terms of the agreement, AstraZeneca will acquire all of the outstanding capital stock of ZS Pharma for $90 per share in an all-cash transaction, or approximately $2.7 billion in aggregate transaction value. ZS PHARMA, INC. Stock Price . NASDAQ 0.00%. ZS Pharma, Inc. ( ZSPH ) saw a big move last session, as the company's shares fell nearly 10% on the day. Their latest funding was raised on Jul 18, 2014 from a Post-IPO Debt round. View real-time stock prices and stock quotes for a full financial overview. Trending now . Sign Up. Small Cap Basic. Real-time trade and investing ideas on ZS Pharma ZSPH from the largest community of traders and investors. China gives approval for broader use of Sinovac vaccine . DOW 0.00%. This website uses cookies so that we can provide you with the best user experience possible. The N/A ratio of ZS Pharma, Inc, is significantly lower than the average of its sector (Pharmaceuticals): 3.33. Upon completion, ZS Pharma, which has around 200 employees across three sites in California, Texas and Colorado, will become a wholly owned subsidiary of AstraZeneca. Watch.